Venusberg Campus 1
WELCOME TO EUROPE’S FIRST
SCN8A & SCN2A CONFERENCE & FAMILY GATHERING
BUILDING A NETWORK ACROSS EUROPE AND BEYOND.
SCN8A and SCN2A related diseases are extremely rare, likely under diagnosed, neurodevelopmental disorders caused by variants to the SCN2A / SCN8A genes.
While sharing similarities with better known Dravet Syndrome (SCN1A), SCN8A/2A are different and can require different treatment.
Improved awareness and early diagnosis are key.
SCN2A & SCN8A also have differences, but as rare sodium-channel disorders there is commonality of research and expertise.
The SCN8A and SCN2A patient network is also growing with families forming groups in respective European nations, with groups connecting across Europe and beyond. This increasingly visible patient network offers helps researchers access and further aids the growth of the patient registries.
At this critical time, the conference brings together specialist clinicians, researchers and patient advocates. This intersection of data, expertise and research will enhance insight into genotype/phenotype relationships, enrich knowledge of optimum therapies, and stimulate ideas for new research streams.
The Department of Epileptology, University Hospital Bonn, is one of the 2 German centers that has been recognised as a European Reference Network (ERN) on rare and complex epilepsies. More at Epi Care